| SciPort RLP

2019 - 2021

T-cell-receptor redirected CD3+ natural killer cells for adoptive immunotherapy to acute myeloid leukemia

Jan,
Dr. Udo F.

2019 - 2020

NKp30-based chimeric antigen receptor redirected human T lymphocytes induce effective antitumoral immune responses to acute myeloid leukemia and melanoma

Dr. Udo F.

2019 - 2021

GRAVITAS-301 (#773)

Dr. Eva Maria

2019 - 2040

GMMG HD7 Trial (#789)

Prof. Dr. Markus,
Prof. Dr. Hartmut

2019 - 2021

Role of GSK-3 in MDS/AML initiation and progression

Dr. Borhane

2019 - 2021

NK-Zell-Subpopulationen in der Prognose von Glioblastomen

Dr. Eva Maria,
Dr. Mirjam

2019 - 2040

ARROW 2 Trial (#1116)

Prof. Dr. Markus,
Prof. Dr. Katja

2019 - 2040

Tumorantigene bei AML/MDS/MM (#1168)

Dr. Eva Maria

2019 - 2020

Multiple Myeloma Resilience Project

Dr. Christina

2019 - 2023

Clinical Development of imiquimod based immunotherapy (TRR156, KS01)

Prof. Dr. Markus

III. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Starten Sie Ihre Suche...

III. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz